Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
B3GAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
WBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01537 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LTBR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UPF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UTRN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SFI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF282 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OXLD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR157 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC88A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STXBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAD1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100996385 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STK38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on